Table 1: FAF1 mRNA expression and clinicopathological characteristics of gastric cancer.

Parameter FAF1 mRNA level**

Gender
 Female110.27 ± 0.120.1920.849
 Male290.26 ± 0.11
Age (years)
 ≥60170.27 ± 0.120.530.599
 <60230.25 ± 0.11
Tumor size (cm)*
 ≥5180.26 ± 0.110.10.921
 <5220.26 ± 0.12
Histological grade
 Well differentiated140.39 ± 0.069.966<0.001
 Poorly differentiated260.19 ± 0.06
Invasion depth
 No serosa invasion70.30 ± 0.121.090.283
 Serosa invasion330.25 ± 0.11
Lymph node metastasis
 Present30.34 ± 0.141.2660.213
 Absent370.25 ± 0.11
Distant metastasis
 Present120.19 ± 0.07−2.7530.009a
 Absent280.29 ± 0.12
Clinical stage
 I + II80.32 ± 0.126.2760.004a
 IIIA + IIIB170.30 ± 0.11
 IV150.18 ± 0.12

*Defined by the longest dimension in the gastric mucosa.
**Normalized to the level of -actin.
a , based on a comparison using a mean ± SD test.